Samantha Ruth Prabhu is one of the most established actresses of south cinema. She has proved that she is one of the best actresses. Film after film, she proved her mettle. However, the actress has now taken a short break from work to focus on her health. A few months ago, Samantha Ruth Prabhu revealed that she was diagnosed with myositis. Latest reports say that the actress is seeking treatment and hence has taken a short break for the same. However, a rumor recently spread that Samantha Ruth Prabhu has to take financial help for treatment.
Samantha Ruth Prabhu reacts to the latest reports
There were whispers that the Yashoda actress sought help and got Rs 25 crore for her treatment. However, as absurd as it sounds, the rumors are not true. Samantha Ruth Prabhu took to her social media to set the record straight and put an end to all the unnecessary reports doing the rounds on the internet. On social networks, she wrote that no one wants so much money for the treatment of myositis. And she also sarcastically said that she hasn’t earned any marbles for all the work she’s done so far and that she can support herself and treat herself. She asked everyone to stop spreading false information. Her message on her Insta stories reads, “Rs 25 Crores to treat myositis!? Someone cut you a pretty bad deal. I’m glad I’m only spending the tiniest bit of it. And I don’t think I get paid in balls for all the work I’ve done in my career. So I can easily take care of myself. Thank you. Myosotis is a condition that affects thousands. Let’s be responsible with the information you put out regarding treatment.”
On the work front, Samantha Ruth Prabhu will soon be seen in Khushi. She will share with Vijay Deverakonda in this one. Their chemistry looks sizzling and fans are excited to see them in a movie together.
Samantha Ruth Prabhu will also be seen in the Indian chapter of Citadel alongside Varun Dhawan.
Stay tuned to BollywoodLife for the latest news and updates from Bollywood, Hollywood, South, TV and web series.
Click to join us on Facebook, TwitterYouTube and Instagram.
Also follow us on Facebook Messenger for the latest updates.